Wed Apr 16 10:28:13 UTC 2025: ## Dolo-650 Consumption Soars in Post-Pandemic India
**New Delhi, [Date]** – Sales of the popular over-the-counter pain reliever Dolo-650 have surged dramatically in India following the Covid-19 pandemic, solidifying its position as a household staple. While the exact figures remain undisclosed, anecdotal evidence and market trends suggest a significant increase in consumption. The reasons behind this rise are currently being analyzed, but it is likely linked to increased self-medication during the pandemic and heightened awareness of the brand. This surge highlights the growing reliance on readily available pain relief medication in India, raising concerns amongst health experts about potential overuse and its long-term consequences.
First Piper 